Biasini, Emiliano
 Distribuzione geografica
Continente #
NA - Nord America 3.485
EU - Europa 542
AS - Asia 232
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 2
Totale 4.270
Nazione #
US - Stati Uniti d'America 3.479
IT - Italia 201
FI - Finlandia 94
SE - Svezia 89
CN - Cina 77
GB - Regno Unito 71
SG - Singapore 66
JO - Giordania 42
DE - Germania 34
VN - Vietnam 24
BG - Bulgaria 20
TR - Turchia 14
UA - Ucraina 8
NL - Olanda 6
CA - Canada 5
EU - Europa 4
IE - Irlanda 4
RU - Federazione Russa 4
IN - India 3
JP - Giappone 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BR - Brasile 2
BY - Bielorussia 2
FR - Francia 2
LU - Lussemburgo 2
AT - Austria 1
DK - Danimarca 1
GR - Grecia 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
VE - Venezuela 1
Totale 4.270
Città #
Fairfield 562
Chandler 505
Ashburn 271
Woodbridge 237
Seattle 230
San Mateo 222
Houston 205
Cambridge 188
Wilmington 174
Ann Arbor 163
Princeton 113
Jacksonville 69
Helsinki 59
Beijing 46
San Diego 38
Trento 37
Dearborn 34
New York 31
Como 26
Singapore 23
San Paolo di Civitate 22
Boardman 20
Fremont 19
Sofia 19
London 18
Dong Ket 14
Izmir 13
Norwalk 12
Tolentino 10
Bassano del Grappa 7
Des Moines 7
Nanjing 7
Perugia 7
Washington 7
Bonndorf 5
Costa Mesa 5
Milan 5
Toronto 5
Altamura 4
Bremen 4
Dublin 4
Shanghai 4
Augusta 3
Berlin 3
Casalecchio di Reno 3
Kilburn 3
Los Angeles 3
Amsterdam 2
Andover 2
Augsburg 2
Catania 2
Cernusco sul Naviglio 2
Chiswick 2
Foligno 2
Groningen 2
Guangzhou 2
Hangzhou 2
Hefei 2
Hounslow 2
Isesaki 2
Jinan 2
Kunming 2
Messina 2
Minsk 2
Nanchang 2
Naples 2
Padova 2
Parma 2
Phoenix 2
Riva Del Garda 2
Rovereto 2
Schio 2
Verona 2
Wandsworth 2
Adelaide 1
Allen 1
Athens 1
Baotou 1
Bastia umbra 1
Caivano 1
Camerino 1
Capriate San Gervasio 1
Carol Stream 1
Catanzaro 1
Changchun 1
Chengdu 1
Chicago 1
Conegliano 1
Distrito Federal 1
Easton 1
Falkenstein 1
Falls Church 1
Farra Di Soligo 1
Florence 1
Fontanelle 1
Frankfurt am Main 1
Hebei 1
Islamabad 1
La Canada Flintridge 1
Lappeenranta 1
Totale 3.546
Nome #
Regulation of HuR structure and function by dihydrotanshinone-I 155
Interfering with HuR-RNA Interaction: Design, Synthesis and Biological Characterization of Tanshinone Mimics as Novel, Effective HuR Inhibitors 155
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein 144
Full atomistic model of prion structure and conversion 134
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein 114
Activation of zebrafish Src family kinases by the prion protein is an amyloid-β-sensitive signal that prevents the endocytosis and degradation of E-cadherin/β-catenin complexes in vivo 111
An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo 108
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity 108
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: A novel pharmacological strategy against brain injury 99
Acute Neurotoxicity Models of Prion Disease 99
Mutant prion protein expression is associated with an alteration of the rab GDP dissociation inhibitor α (GDI)/rab11 pathway 98
The prion protein family member Shadoo induces spontaneous ionic currents in cultured cells 97
The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers 89
A novel, drug-based, cellular assay for the activity of neurotoxic mutants of the prion protein 86
null 86
Pharmacological Agents Targeting the Cellular Prion Protein 85
Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases 84
The hydrophobic core region governs mutant prion protein aggregation and intracellular retention 83
Pharmacological inactivation of the prion protein by targeting a folding intermediate 83
Common therapeutic strategies for prion and Alzheimer's diseases 82
The N-terminal, polybasic region is critical for prion protein neuroprotective activity 81
Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity 79
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein 79
Ok google, how could i design therapeutics against prion diseases? 78
A Drug-Based Cellular Assay (DBCA) for studying cytotoxic and cytoprotective activities of the prion protein: A practical guide 78
The N-terminal, polybasic region of PrP C dictates the efficiency of prion propagation by binding to PrP Sc 77
All-Atom Simulation of HET-s Prion Replication 75
Epitope scanning indicates structural differences in brain-derived monomeric and aggregated mutant prion proteins related to genetic prion diseases 74
The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells 72
Proteasome inhibition and aggregation in Parkinson's disease: A comparative study in untransfected and transfected cells 72
A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity 72
An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity 72
Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities 71
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 69
GFP-tagged mutant prion protein forms intra-axonal aggregates in transgenic mice 68
Characterization of Physical, Mechanical, and Biological Properties of SilkBridge Nerve Conduit after Enzymatic Hydrolysis 68
Immunopurification of pathological prion protein aggregates 67
The cellular prion protein beyond prion diseases 64
Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans 63
Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation 63
null 62
Non-infectious aggregates of the prion protein react with several PrP Sc-directed antibodies 61
A designer chaperone against prion diseases 61
Understanding prion structure and conversion 59
Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion 54
Targeting the cellular prion protein to treat neurodegeneration 53
Modeling PrPSc Generation Through Deformed Templating 53
Generation, optimization and characterization of novel anti-prion compounds 53
Role of lipid rafts and GM1 in the segregation and processing of prion protein 49
The Compelling Demand for an Effective PrPC-Directed Therapy against Prion Diseases 47
Prion protein ligands as therapeutic agents for neurodegenerative disorders 40
Astrocytic microdomains from mouse cortex gain molecular control over long-term information storage and memory retention 38
Ion channels induced by the prion protein: Mediators of neurotoxicity 36
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia 34
A Method for Identifying Intermediates 26
Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse 24
Infectious and pathogenic forms of PrP 23
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency 22
Redox regulation of cyclophilin A by glutathionylation 21
Functional, pathogenic, and pharmacological roles of protein folding intermediates 19
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 16
null 11
Pliability in the m6A-Binding Region Extends Druggability of YTH Domains 10
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies 10
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 10
Prion protein at the crossroads of physiology and disease 9
Gene expression profiling in trigeminal ganglia from Cntnap2-/- and Shank3b-/- mouse models of autism spectrum disorder 8
Identification of the zebrafish homologues of IMPG2, a retinal proteoglycan 1
Totale 4.452
Categoria #
all - tutte 24.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 400
selected - selezionate 0
volume - volumi 712
Totale 25.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019110 0 0 0 0 0 0 0 0 0 0 0 110
2019/2020920 49 32 58 110 91 77 111 100 144 79 41 28
2020/2021743 33 52 28 53 29 108 51 83 50 112 98 46
2021/2022852 52 217 7 33 8 21 35 190 35 63 99 92
2022/2023997 102 129 6 139 110 151 7 69 163 21 51 49
2023/2024407 21 52 23 20 36 86 48 38 4 14 12 53
Totale 4.452